The market for genetic testing emerged in the early 2000s as a result of the global scientific success in mapping the human genome in the decade prior. The Human Genome Project enabled scientists to perform ever more complex and important medical research and also made it possible for biotechnology companies to develop and offer a variety of genetic tests. These tests, which were often administered through clinics, provided patients with insights about their genetic predisposition towards certain diseases. However, the past decade has witnessed tremendous growth in direct-to-consumer (DTC) genetic tests, whereby consumers can purchase kits to learn more about their genetic profiles without the direct involvement of a healthcare provider as an intermediary.
